LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 42.67 | 771.67 | 2784 | 5155 | 0.5400 | 0.5972 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 42.67 | 771.67 | 2687 | 5155 | 0.5212 | 0.5767 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 44.89 | 771.67 | 2448 | 5541 | 0.4418 | 0.5007 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 44.89 | 771.67 | 2977 | 5541 | 0.5372 | 0.6075 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 44.89 | 771.67 | 2848 | 5541 | 0.5139 | 0.5827 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 47.11 | 771.67 | 2552 | 5941 | 0.4295 | 0.5011 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 47.11 | 771.67 | 3188 | 5941 | 0.5366 | 0.6189 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 47.11 | 771.67 | 3011 | 5941 | 0.5068 | 0.5878 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 49.33 | 771.67 | 2722 | 6392 | 0.4258 | 0.5117 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 49.33 | 771.67 | 3393 | 6392 | 0.5308 | 0.6250 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 49.33 | 771.67 | 3161 | 6392 | 0.4945 | 0.5877 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 51.55 | 771.67 | 2808 | 6829 | 0.4111 | 0.5077 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 51.55 | 771.67 | 3545 | 6829 | 0.5191 | 0.6237 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 51.55 | 771.67 | 3290 | 6829 | 0.4817 | 0.5856 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 53.77 | 771.67 | 2962 | 7256 | 0.4082 | 0.5159 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 53.77 | 771.67 | 3790 | 7256 | 0.5223 | 0.6360 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 53.77 | 771.67 | 3423 | 7256 | 0.4717 | 0.5853 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 55.99 | 771.67 | 3195 | 7690 | 0.4155 | 0.5347 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 55.99 | 771.67 | 4038 | 7690 | 0.5251 | 0.6470 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 55.99 | 771.67 | 3571 | 7690 | 0.4644 | 0.5871 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 58.21 | 771.67 | 3370 | 8085 | 0.4168 | 0.5449 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 58.21 | 771.67 | 4323 | 8085 | 0.5347 | 0.6627 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 58.21 | 771.67 | 3739 | 8085 | 0.4624 | 0.5930 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 60.44 | 771.67 | 3497 | 8530 | 0.4099 | 0.5464 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 60.44 | 771.67 | 4482 | 8530 | 0.5254 | 0.6611 | MN20160304_L01 | H12 |